Company intelligence / Profile preview

SBB

Germanysbb.ch ↗
Ownership
Private
Development stage
Other
01

Overview

S.B. Pharma Group provides end-to-end pharmaceutical solutions including distribution of raw materials/APIs, development/manufacturing/registration of finished dosage forms (FDF), drug-device combinations, and medical devices. Their FDF portfolio includes over 1800+ products in 10 dosage forms across various therapeutic categories with a focus on both prescription drugs (Rx) and OTC medicines[4].

They hold ISO 9001 certification for quality management systems and comply with Good Distribution Practice guidelines; they are registered in the EUDRA database with pharmaceutical wholesaler authorization under German law[4].

Their business model emphasizes flexibility to local requirements worldwide.

Clinical results not applicable—company focuses on product development/commercialization rather than clinical-stage innovation.

Modalities
Small moleculeMedical deviceDrug-device combination therapy
Industry
Contract Manufacturing Organization

Beyond the preview

Go deeper on SBB.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from trial design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Licensing & deals

Full profile access

Explore licensing agreements, acquisitions, and the assets behind each deal.

  • Partners
  • Deal terms
  • Milestones

Funding history

Full profile access

Trace financing activity and the investors behind a company’s development.

  • Funding rounds
  • Investors
  • Capital raised

Competitive landscape

Full profile access

Compare peer pipelines by target, modality, and therapeutic area.

  • Peer companies
  • Targets
  • Pipeline overlap

Technologies & patents

Full profile access

Explore technology platforms and the patent landscape around relevant assets.

  • Platforms
  • Patents
  • Assignees

Research & analysis

Full profile access

Connect company news and source material to the questions you’re investigating.

  • Company news
  • Sources
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on SBB.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call